Walmart Recalls 11 Products as Cyclospora Outbreak Spreads to 4,200 Cases

Walmart has issued recalls for 11 products, with the most serious involving Marketside bagged salads linked to a cyclospora outbreak that has infected nearly 4,200 people across 27 states. The parasitic illness has hospitalized 308 patients. An 84-year-old Georgia man spent eight days in intensive care after consuming contaminated lettuce. Consumers should discard recalled items or return them for refunds.

The cyclospora outbreak tied to Walmart salads

Marketside bagged iceberg salads sold at Walmart may carry the cyclospora parasite, which causes severe gastrointestinal illness. The CDC confirmed nearly 4,200 cases as of July 23, 2026, with 308 hospitalizations. The affected products were sold across 27 states under four UPC codes. Symptoms include watery diarrhea, fatigue, loss of appetite, and stomach cramps that typically appear one week after exposure.

Other Walmart recalls affecting homes and families

Beyond the salad recall, Walmart is pulling 10 additional products from shelves. Morningstar Farms plant-based products may contain plastic pieces, Gas-X softgels face contamination with diluted coolant, and Evenflo Revolve360 child car seats number 59,661 units recalled for safety defects. Consumers should inspect refrigerators, kitchens, garages, and backyards for these items.

What to do if you own recalled products

Walmart advises customers to stop using recalled items immediately. Depending on the product, consumers can dispose of it safely or return it to Walmart for a full refund. Anyone experiencing diarrhea, fatigue, or loss of appetite after consuming bagged salad should seek medical advice. Kentucky alone reported 468 cases of cyclospora as of July 22, a 400 percent increase over the typical annual count of 35 cases.

Stock impact and investor implications

WMT stock rose 0.98 percent to $109.47 on July 26 despite the recall crisis. Meyka grades the stock a B with a neutral hold recommendation. Analysts rate WMT with a consensus buy rating, but the stock trades at a 38.4 price-to-earnings ratio and sits 8 percent below its 50-day average. The recall adds reputational risk to a retailer already facing margin pressure.

Final Thoughts

Walmart’s multi-product recall, anchored by a cyclospora outbreak affecting 4,200 people, poses both immediate health and brand risks. With Meyka grading WMT a B and analysts split between buy and hold, the stock faces near-term uncertainty as the company manages food safety fallout and consumer confidence erosion.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.